All 9 /Events 0 /In The News 3 /Press Releases 6

NRG Therapeutics Launches MND Drug Discovery Programme and Announces new Collaboration in Australia

NRG’s second therapeutic programme to explore brain penetrant…
16 December 2021/by Webadm

Parkinson’s UK takes investment in NRG Therapeutics to £2.5m

Business Weekly
23 August 2021/by Webadm

Parkinson’s UK invests a further £490k in NRG Therapeutics to Progress Parkinson’s Drug Discovery Programme

NRG Therapeutics Ltd (“NRG” or “company”), an innovative…
23 August 2021/by Webadm

Cambridge neuroscience specialist NRG Therapeutics secures $500,000 from The Michael J Fox Foundation for Parkinson’s Research

Cambridge Independent

Read more
4 August 2021/by Webadm

NRG Therapeutics Awarded $500K Grant from The Michael J. Fox Foundation to Progress Parkinson’s Programme

NRG Therapeutics Ltd (“NRG” or “company”), an innovative…
29 July 2021/by Webadm

NRG Therapeutics wins $500K from Michael J. Fox Foundation for Parkinson’s programme

Business Weekly
29 July 2021/by Webadm

Parkinson’s UK continues drug discovery with NRG Therapeutics Ltd

Parkinson's UK has invested an additional £1 million in NRG…
7 August 2020/by Webadm

Dr Richard Seabrook joins Board of NRG Therapeutics

Richard brings over 25 years of experience in scientific translation…
5 November 2019/by Webadm

Charity invests £1 million to develop a treatment to slow down progression of Parkinson’s

Charity Parkinson’s UK is partnering with NRG Therapeutics…
1 July 2019/by Webadm

NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project

NRG Therapeutics Ltd., an innovative neuroscience company targeting…

NRG Therapeutics to develop small molecule disease-modifying medicines for debilitating chronic neurodegenerative disorders

Drug Target Review

£2.68M Award to NRG Therapeutics Supports Work Into Potential DMT

Parkinson’s News Today Read more

NRG receives £2.68m funding boost for neurodegenerative disorders

Pharma Times Read more

NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson’s and Motor Neurone Disease

£2.68 million Biomedical Catalyst (BMC) early-stage award…

Sticking plaster for brain could beat Parkinson’s disease

Sunday Times Read more (behind a paywall)

NRG Therapeutics awarded £2.68m to fight Parkinson’s and MND

Business Weekly Read more